Market Overview

Benzinga's Top Downgrades

Related JCP
No Legwork Wednesday – J.C. Penney And The 'No Sale' Debacle
Top 4 NYSE Stocks In The Department Stores Industry With The Highest Revenue
Citi Boosts J.C. Penney to 'Buy' from 'Neutral' (Fox Business)
Related ENTR
Benzinga's Top Pre-Market Losers
Benchmark Company Reiterates Buy on Entropic Communications Following Mixed Results

Analysts at Citigroup downgraded J.C. Penney Company (NYSE: JCP) from “neutral” to “sell.” The target price for J.C. Penney has been lowered from $20 to $11. J.C. Penney's shares closed at $14.60 yesterday.

Benchmark downgraded Entropic Communications (NASDAQ: ENTR) from “buy” to “hold.” The target price for Entropic Communications has been lowered from $6 to $4. Entropic's shares closed at $4.43 yesterday.

ISI Group downgraded MedAssets (NASDAQ: MDAS) from “strong buy” to “buy.” The target price for MedAssets has been raised from $23 to $24.50. MedAssets's shares closed at $21.77 yesterday.

Analysts at Bank of America downgraded Covance (NYSE: CVD) from “buy” to “neutral.” The target price for Covance has been raised from $81 to $85. Covance's shares closed at $82.50 yesterday.

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Most Popular

Related Articles (ENTR + CVD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free